Epigenetics and autosomal dominant polycystic kidney disease
- 20 October 2010
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (10), 1213-1218
- https://doi.org/10.1016/j.bbadis.2010.10.008
Abstract
No abstract availableFunding Information
- Polycystic Kidney Disease Charity
- National Institutes of Health (R01 DK084097)
This publication has 102 references indexed in Scilit:
- Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD modelsProceedings of the National Academy of Sciences of the United States of America, 2009
- Wnt Signaling from Development to Disease: Insights from Model SystemsCold Spring Harbor Perspectives in Biology, 2009
- Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networksHuman Molecular Genetics, 2009
- HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary CiliumCell, 2007
- Sirtuins in mammals: insights into their biological functionBiochemical Journal, 2007
- Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2Molecular and Cellular Biology, 2007
- Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle DifferentiationMolecular and Cellular Biology, 2007
- Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanismsJournal of the American Society for Mass Spectrometry, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- The language of covalent histone modificationsNature, 2000